Risk-adjusted follow-up may help catch bladder cancer recurrences after cystectomy
January 10, 2014 — NEW YORK (Reuters Health) - Physicians should consider tumor
stage, surgical margins, and other factors when setting
follow-up schedules for patients who have undergone cystectomy
for bladder cancer, a new study suggests.
FDA approves new type 2 diabetes drug
January 8, 2014 — (Reuters) - U.S. health regulators on Wednesday approved an
AstraZeneca drug from a new class of medicines to treat type 2
diabetes after previously rejecting it over safety concerns.
FDA staff cautious on diabetes drug dapagliflozin
December 10, 2013 — LONDON (Reuters) - U.S. Food and Drug Administration staff
said on Tuesday they were wary about the benefits versus the
risks of AstraZeneca and Bristol-Myers Squibb's new diabetes
Select news items provided by Reuters Health